Nebivolol 0.5, 1.0, or Timolol 0.5 Suspension Compared to Timolol 0.5 Solution to Treat Glaucoma/Ocular Hypertension
Status:
Recruiting
Trial end date:
2022-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety (in the eye and throughout the body) and
effectiveness of nebivolol (0.5 and 1 percent) and timolol (0.5 percent) eye drop
suspensions. These eye drops will be compared to timolol 0.5 percent eye drop solution in
participants with open angle glaucoma (the most common type of glaucoma) or high eye pressure
(ocular hypertension).